Results 201 to 210 of about 25,866 (234)

Analyzing Insights of Super-Response in Cardiac Resynchronization Therapy with Fusion Pacing. [PDF]

Diagnostics (Basel)
Lazăr-Höcher AI, Crișan S, Văcărescu C, Nistor S, Faur-Grigori AA, Cozgarea A, Baneu P, Cirin L, Brăescu L, Dăniluc L, Gaiță D, Luca CT, Cozma DC.   +12 more
europepmc   +1 more source

A Challenging Case of Wild-Type Transthyretin Amyloidosis (ATTR) Amyloidosis Treated With Cardiac Resynchronization Therapy. [PDF]

Cureus
Bansho H, Tomioka D, Geshi T, Sakai H, Nakagawa Y.   +4 more
europepmc   +1 more source

Long-term outcomes of upgrading to cardiac resynchronization therapy in patients with left bundle branch block or right ventricular pacing. [PDF]

Heart Rhythm O2
Oshima Y, Ueda N, Ishibashi K, Nakamura T, Oka S, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kusano K.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cardiac resynchronization therapy

British Journal of Hospital Medicine, 2013
This article provides an overview of cardiac resynchronization therapy. At the end of the article, the reader should be familiar with the indications, risks and complications of cardiac resynchronization therapy and important areas of debate.
V, Cobb, M, Thomas
openaire   +3 more sources

Cardiac Resynchronization Therapy

JACC: Clinical Electrophysiology, 2022
Abstract This chapter examines cardiac resynchronization therapy (CRT), or biventricular pacing (BVP), which is now well established as a therapeutic option for selected, symptomatic patients with heart failure due to left ventricular systolic dysfunction and reduced ejection fraction (HFrEF) and a prolonged QRS interval.
Varun Sundaram, Judith A. Mackall
openaire   +2 more sources

Cardiac resynchronization therapy

Current Cardiology Reports, 2002
Despite advances in medical therapy for patients with congestive heart failure, morbidity and mortality remain high. Conventional atrioventricular pacing with a short atrioventricular delay was first introduced as a nonpharmacologic treatment for patients with severe heart failure.
Silke Isabelle, Trautmann, Michael, Kloss, Angelo, Auricchio   +2 more
openaire   +4 more sources

Cardiac resynchronization therapy.

Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular, 2012
Heart failure can potentially complicate all forms of heart disease. Over the last 20 years, there has been a significant increase in both its incidence and prevalence due to the advancing age of the population and improved survival from coronary heart disease – the principal cause of heart failure.
Maria C Valéria Braga Braile, Sternieri, Victor Rodrigues Ribeiro, Ferreira   +1 more
  +7 more sources

Cardiac Resynchronization Pacing Therapy

Cardiology, 2004
Approximately one third of patients with congestive heart failure and systolic dysfunction have an intraventricular conduction delay that is manifested as a QRS duration >120 ms. An intraventricular conduction delay adversely affects ventricular performance by causing dyssynchrony in ventricular activation.
Cash, Casey, Bradley P, Knight
openaire   +2 more sources

Cardiac Resynchronization Therapy

Progress in Cardiovascular Diseases, 2006
Left ventricular (LV) dysynchrony, generally defined as the effect of intraventricular conduction defects or bundle branch block to produce nonsynchronous ventricular activation, places the failing heart at a further mechanical disadvantage. The deleterious effects of ventricular dysynchrony include suboptimal ventricular filling, paradoxical septal ...
openaire   +3 more sources